Investor Ideas #Potcasts; #Cannabis
News and Stocks on the Move; TSX: $ACB.TO, CSE: $CRZ.C, CSE: $CROP.C, TSXV: $FIRE.V
July 11th Potcast
sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis
company with a new disruptive drug delivery platform: DehydraTECH
Pt. Roberts, WA; Delta, BC – July 11,
2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/07112Potcasts-TSX-ACB-CSE-CRZ-CROP-FIRE.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast; looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today’s podcast features news announcements from Aurora Cannabis Inc. (TSX:
ACB and OTCQB:
ACBFF) ,
CannaRoyalty Corp. (CSE:
CRZ) , CROP Infrastructure ( CSE:
CROP and OTC:
CRXPF) and The Supreme Cannabis Company (TSX-Venture:
FIRE) .
Aurora
Cannabis Inc. announced today the signing a binding term sheet with
CannaRoyalty Corp. (CSE: CRZ), whereby Aurora is purchasing CannaRoyalty's exclusive
Canadian license to use and commercialize pre-roll technology developed by
Wagner Dimas for an aggregate consideration of C$7 million in Aurora common
shares. Closing of the Agreement is subject to certain conditions, including
regulatory approval.
The
transaction includes cash and the issuance of common shares of Aurora relative
to the achievement of certain milestones for the joint commercialization of
Wagner Dimas's technology. This technology targets the high-volume,
higher-margin pre-rolled segment of the cannabis market.
Under the
terms of the agreement, Aurora and Wagner Dimas will form a new Canadian entity
to which Wagner Dimas has agreed to assign intellectual property with exclusive
rights to Aurora. The transaction is subject to completion of definitive
agreements, delivery of certain equipment from Wagner Dimas to Aurora -
expected within the next 21 days - as well as customary TSX and regulatory
approvals.
Aurora has
identified the pre-roll market segment as a high-volume, higher-margin
opportunity. BDS-Analytics, for instance, determined that pre-rolls account for
12% of total revenue generated from the adult consumer market in Washington
State (2017). Wagner Dimas produced over 5 million pre-rolls in 2017, and,
following scale-up to a new facility, the company is on pace to produce over 50
million pre-rolls in 2018 for the Californian market alone. Furthermore, the
Wagner Dimas technology enables the production of over 75 different pre-rolled
product types, addressing a wide variety of market demands. Wagner Dimas
provides pre-rolls to a wide range of the most popular brands in the California
market.
Aurora
Cannabis Inc. also announced today that it has established a partnership
agreement with Evio Beauty Group Ltd. pursuant to which Aurora has made a
strategic investment in Evio Beauty. Under the terms of the Agreement, Aurora
and Evio Beauty Group will collaborate to develop a line of co-branded hemp
seed oil cosmetic products ("Non-Infused Products") as well as a collection
of CBD infused cosmetic products ("Infused Products").
The
partnership between Evio Beauty and Aurora is aimed at creating a new line of
approved hemp seed oil based product formulations, as well as approved CBD
based products. Aurora and Evio Beauty anticipate that the partnership will
result in greater brand recognition and cross-selling opportunities to
customers of both companies.
CROP Infrastructure Corp. announced
its 30% owned Italy Joint Venture partner 'XHemplar Italia' has planted 25
acres or 1,089,000 square feet of high CBD 'Cannabis Light' in North Eastern
Italy. This represents over a 100% increase on the previously announced
capacity announced in press release dated June 27th 2018.
The Joint
Venture's resulting high CBD "Cannabis Light" will be processed and
sold into international CBD markets under white label, the venture's house name
XHemplar and Crop brands Tiffany CBD and Hempire Italia. The company will also
use the production to infuse its recently announced therapeutic and cosmetic
product lines, licensed from The Yield Growth Corp., which transaction is now
complete giving Crop exclusive rights in Italy to over 55 wellness products.
According to
Arcview Market Research and its partner, BDS Analytics, government-subsidized
healthcare spending (worldwide market at $1.3-trillion) is expected to make
Europe among the fastest growing and largest medical cannabis markets in the
world. Arcview expects Italy to be the second largest cannabis market in Europe
by 2027 with $1.2 billion in sales.
The Supreme
Cannabis Company today announced that it has obtained Health Canada approval to
commence cultivation on approximately 30,000 square feet of additional
flowering rooms at its 7ACRES facility. The new capacity is expected to double
7ACRES' estimated annual production from 5,000kg to 10,000kg.
The
proprietary technology and modular design of 7ACRES' facility has allowed for
the rapid scaling of operations while maintaining industry-leading product
quality, production standards and minimizing execution risk.
Total
completion of growing rooms at the 342,000-square foot 7ACRES facility is on
schedule for completion in December 2018.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Lexaria Bioscience Corp. has developed and out-licenses
its disruptive delivery technology that promotes healthier ingestion methods,
lower overall dosing and higher effectiveness of lipophilic active molecules.
Lexaria has multiple patents pending in over 40 countries around the world and
has patents granted in the USA and in Australia for utilization of its
DehydraTECHTM delivery technology. Lexaria's technology provides increases in
intestinal absorption rates; more rapid delivery to the bloodstream; and
important taste-masking benefits, for orally administered bioactive molecules
including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs
(NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on
Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
